Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Dong Liu, Qianni Wu, Yuqiong Zhu, Yijun Liu, Xiuli Xie, Sihan Li, Haotian Lin, Weirong Chen & Fangming Zhu. (2019) Co-delivery of metformin and levofloxacin hydrochloride using biodegradable thermosensitive hydrogel for the treatment of corneal neovascularization. Drug Delivery 26:1, pages 522-531.
Read now
Read now
Frank A Bucci$suffix/text()$suffix/text(), Ines Teuma Nguimfack & Angel T Fluet. (2016) Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery. Clinical Ophthalmology 10, pages 783-789.
Read now
Read now
Darlene Miller. (2013) Pharmacological treatment for infectious corneal ulcers. Expert Opinion on Pharmacotherapy 14:5, pages 543-560.
Read now
Read now
Articles from other publishers (13)
Lauren E. Page, Melissa A. Kubai, Rachel A. Allbaugh, Leila Bedos, Mackenzie M. Roy, Jonathan P. Mochel & Lionel Sebbag. (2023) Increased drug concentration and repeated eye drop administration as strategies to optimize topical drug delivery: A fluorophotometric study in healthy dogs. Veterinary Ophthalmology 26:4, pages 331-338.
Crossref
Crossref
Takashi SuzukiToshihiro YamamotoTomohiko TorikaiYuichi Ohashi. (2017) Combination Effect of Cefuroxime and Levofloxacin Against Bacteria Isolated from the Healthy Conjunctival Sac and Endophthalmitis Cases Using a Fractional Inhibitory Concentration Index. Journal of Ocular Pharmacology and Therapeutics 33:1, pages 19-23.
Crossref
Crossref
Esther S. Kim & Katherine A. Lyseng-Williamson. (2016) Levofloxacin hydrate 1.5 % ophthalmic solution in external ocular infections and intraocular surgery: a guide to its use. Drugs & Therapy Perspectives 32:11, pages 449-455.
Crossref
Crossref
Trisha Sharma, M Manjunath Kamath, M Gurudutt Kamath, Rajesh R Nayak, K L Bairy & Prashant B Musmade. (2015) Aqueous penetration of orally and topically administered moxifloxacin. British Journal of Ophthalmology 99:9, pages 1182-1185.
Crossref
Crossref
Mariann Fodor, Goran Petrovski, Dorottya Pásztor, Péter Gogolák, Éva Rajnavölgyi & András Berta. (2014) Effects of Awakening and the Use of Topical Dexamethasone and Levofloxacin on the Cytokine Levels in Tears Following Corneal Transplantation. Journal of Immunology Research 2014, pages 1-8.
Crossref
Crossref
Dale W. BratzlerE. Patchen DellingerKeith M. OlsenTrish M. PerlPaul G. AuwaerterMaureen K. BolonDouglas N. FishLena M. NapolitanoRobert G. SawyerDouglas SlainJames P. SteinbergRobert A. Weinstein. (2013) Clinical practice guidelines for antimicrobial prophylaxis in surgery. American Journal of Health-System Pharmacy 70:3, pages 195-283.
Crossref
Crossref
Dale W. BratzlerE. Patchen DellingerKeith M. OlsenTrish M. PerlPaul G. AuwaerterMaureen K. BolonDouglas N. FishLena M. NapolitanoRobert G. SawyerDouglas SlainJames P. SteinbergRobert A. Weinstein. (2013) Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery. Surgical Infections 14:1, pages 73-156.
Crossref
Crossref
Eric D. Donnenfeld, Timothy L. Comstock & Joel W. Proksch. (2011) Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. Journal of Cataract and Refractive Surgery 37:6, pages 1082-1089.
Crossref
Crossref
Ngamjit Kasetsuwan, Pinnita Tanthuvanit & Usanee Reinprayoon. (2011) The efficacy and safety of 0.5% Levofloxacin versus fortified Cefazolin and Amikacin ophthalmic solution for the treatment of suspected and culture-proven cases of infectious bacterial keratitis: a comparative study. Asian Biomedicine 5:1, pages 77-83.
Crossref
Crossref
Thomas Walters, Mike Rinehart, William Krebs & Mark Holdbrook. (2010) Tear Concentration and Safety of Levofloxacin Ophthalmic Solution 1.5% Compared With Ofloxacin Ophthalmic Solution 0.3% After Topical Administration in Healthy Adult Volunteers. Cornea 29:3, pages 263-268.
Crossref
Crossref
Joel W. ProkschCamille P. GranvilRaphaële Siou-MermetTimothy L. ComstockMichael R. PaternoKeith W. Ward. (2009) Ocular Pharmacokinetics of Besifloxacin Following Topical Administration to Rabbits, Monkeys, and Humans. Journal of Ocular Pharmacology and Therapeutics 25:4, pages 335-344.
Crossref
Crossref
Joseph A Elias & Rahul T Pandit. (2009) Primary Neisseria meningitidis Keratitis. Cornea 28:6, pages 714-715.
Crossref
Crossref
Stephen V. Scoper. (2008) Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. Advances in Therapy 25:10, pages 979-994.
Crossref
Crossref